Erschienen in:
01.04.2008 | Editorial
Breast cancer surface receptors predict risk for developing brain metastasis and subsequent prognosis
verfasst von:
Jai Grewal, Santosh Kesari
Erschienen in:
Breast Cancer Research
|
Ausgabe 2/2008
Einloggen, um Zugang zu erhalten
Abstract
Determining the status of breast cancer surface receptors (estrogen receptor, progesterone receptor, HER2/neu) has become routine in the care of patients with this disease and has proven to be helpful in guiding treatment. For this reason, breast cancer has become a model for molecularly guided therapy in solid tumors. Emerging data support that these receptors are associated with risk for developing brain metastases. Additionally, once brain metastases have occurred these receptors may also correlate with prognosis.